M48.10
Ankylosing hyperostosis [Forestier], site unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Ankylosing hyperostosis, also known as Forestier's disease, is a condition characterized by the abnormal growth of bone along the sides of the spine and sometimes other parts of the skeleton. This excessive ossification leads to stiffness and can restrict movement, particularly in the spine. Often diagnosed through imaging, this condition primarily affects middle-aged and older adults. While it can be asymptomatic in the early stages, as it progresses, patients may experience pain, reduced flexibility, and other related symptoms.
Causes & Symptoms
Clinical Causes: Degenerative changes related to aging Genetic predisposition, although specific genes have not been definitively identified Chronic mechanical stress or trauma to the spine Metabolic or hormonal factors that influence bone growth Certain inflammatory conditions, though less common
Key Symptoms: Gradual development of stiffness and reduced range of motion in the affected areas Persistent or intermittent back pain Difficulty performing movements that require spinal flexibility In some cases, nerve compression symptoms such as numbness, tingling, or weakness if nerve roots are affected Postural changes, including a forward-stooped appearance in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosing ankylosing hyperostosis involves a combination of clinical evaluation and imaging studies. Key diagnostic methods include: - **Medical history and physical examination**: Assessing for stiffness, pain, and functional limitations. - **X-rays**: The primary imaging modality, revealing characteristic flowing ossifications along the spine's anterior longitudinal ligament. - **Computed Tomography (CT) scans**: Providing detailed images of the bone growths. - **Magnetic Resonance Imaging (MRI)**: Useful for assessing any nerve impingement or soft tissue involvement. There are no specific laboratory tests for this condition, but blood tests may be used to rule out other causes of back pain or inflammation.
Treatment Protocols: Management of ankylosing hyperostosis focuses on alleviating symptoms and maintaining mobility. Treatment options may include: - **Physical therapy**: Exercises to improve flexibility, strength, and posture. - **Medications**: Non-steroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. - **Pain management**: Use of analgesics as prescribed. - **Lifestyle modifications**: Regular activity and ergonomic adjustments to support spine health. - **In severe cases**: Surgical intervention may be considered to relieve nerve compression or correct deformities. It is important to work closely with healthcare providers to develop a tailored management plan that addresses individual needs and disease progression.
Clinical Advice & FAQs
Billing Guidance
Is M48.10 a billable ICD-10 code?
Yes, M48.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M48.10?
Clinical documentation must specify the nature of Ankylosing hyperostosis [Forestier], site unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference